Astellas Pharma (Germany) Story

YPH Stock  EUR 8.91  0.36  3.88%   
Slightly above 62% of Astellas Pharma's investor base is looking to short. The analysis of current outlook of investing in Astellas Pharma suggests that many traders are alarmed regarding Astellas Pharma's prospects. Astellas Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Astellas Pharma. The current market sentiment, together with Astellas Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Astellas Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Astellas Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Astellas daily returns and investor perception about the current price of Astellas Pharma as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Astellas Pharma.

Astellas Pharma Latest Timeline

Astellas Pharma is currently traded for 8.91on Munich Exchange of Germany. The company last dividend was issued on the 27th of March 1970. Astellas Pharma had 5:1 split on the 27th of March 2014.
Check out Astellas Pharma Hype Analysis, Astellas Pharma Correlation and Astellas Pharma Performance.
Note that the Astellas Pharma information on this page should be used as a complementary analysis to other Astellas Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Astellas Stock analysis

When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Please note, there is a significant difference between Astellas Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astellas Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astellas Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.